Introduction: The number of people with dementia, including Alzheimer's disease, is growing
as a result of an ageing global population. Treatments available for AD only alleviate the …

In recent years, Alzheimer disease (AD) has received great attention as an incurable and
fatal disease that threatens the lives of aging individuals. Debates regarding areas of …

Deposits of amyloid plaques and neurofibrillary tangles of aggregated tau in the brain
represent key hallmarks of the neurodegenerative disorder, Alzheimer's Disease (AD) and …

Alzheimer's disease (AD) is one type of neurodegenerative diseases, which is prevalent in
the elderly. Beta-amyloid (Aβ) plaques and phosphorylated tau-induced neurofibrillary …

Background: The goal of slowing or halting the development of Alzheimer disease (AD) has
resulted in the huge allocation of resources by academic institutions and pharmaceutical …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain
associated with memory impairment, progressive cognitive decline and changes in …

Alzheimer's disease (AD) is the major cause of dementia that is now threatening the lives of
billions of elderly people on the globe, and recent progress in the elucidation of the …

Introduction: With an ageing global population, the number of people with dementia, and its
main cause Alzheimer's disease (AD), is growing. current licensed treatments available for …

To date, no truly efficacious drugs for Alzheimer's disease (AD) have been developed;
moreover, all new anti-AD drugs developed since 2003 have failed. To succeed where …

Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places
a substantial burden on patients, their families, and society. Alzheimer's disease (AD) is the …